Caitlin Maloney has notable professional experience on budget & appropriations, healthcare, medicare & medicaid, tax, and trade (domestic & foreign) issues. Caitlin previously worked at ALSTON & BIRD, LLP with no active client. Caitlin has represented 1 total client.

Practice Areas

Areas of Experience

Novo Nordisk Inc. - Pharmaceutical manufacturer
Duration : 1.2 years (2014 - 2015) inactive
Revenue : $20,000.00 (monthly) - $310,000.00 (total)
- The Preventive Health Savings Act (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; FY16 Labor/HHS/Education Appropriations (National Diabetes Prevention Program).
Novo Nordisk Inc. - Pharmaceutical manufacturer
Duration : 1.2 years (2014 - 2015) inactive
Revenue : $20,000.00 (monthly) - $310,000.00 (total)
- National Diabetes Prevention Program; Better care and treatment of people with diabetes under Pub. L. 111-148, the Patient Protection and Affordable Care Act of 2009 (ACA) and Pub. L. 111-152, the Health Care and Education Affordability Reconciliation Act of 2010; Issues related to diabetes generally; H.R. 1192/S.586, the National Diabetes Clinical Care Commission Act; H.R. 8, the American Taxpayer Relief Act(Special Diabetes Program reauthorization); The Protecting Seniors' Access to Medicar...
Novo Nordisk Inc. - Pharmaceutical manufacturer
Duration : 1.2 years (2014 - 2015) inactive
Revenue : $20,000.00 (monthly) - $310,000.00 (total)
- Issues related to Medicare Part D and Medicaid rebates as contained in Pub. L. 112-25, the Budget Control Act of 2011 and H.R. 8, the American Taxpayer Relief Act of 2012; Medicare diabetes screening generally; H.R. 6, 21st Century Cures Act; Treat and Reduce Obesity Act (H.R. 2404/S. 1509); H.R. 2102/S.1131, the Medicare Diabetes Prevention Act.

TAX

Novo Nordisk Inc. - Pharmaceutical manufacturer
Duration : 1.2 years (2014 - 2015) inactive
Revenue : $20,000.00 (monthly) - $310,000.00 (total)
- Corporate tax inversions.
Novo Nordisk Inc. - Pharmaceutical manufacturer
Duration : 1.2 years (2014 - 2015) inactive
Revenue : $20,000.00 (monthly) - $310,000.00 (total)
- Transatlantic Trade and Investment Partnership (TTIP) as it relates to intellectual property; Trade Promotion Authority (H.R. 1890/S. 995/H.R.1295/H.R.1267)

Top Expertise

  • BUDGET & APPROPRIATIONS
  • HEALTHCARE
  • MEDICARE & MEDICAID
  • TAX
  • TRADE (DOMESTIC & FOREIGN)

Clients

Current

Past

  • Novo Nordisk Inc.